Biology Reference
In-Depth Information
Allen, E., Ding, J., Wang, W., Pramanik, S., Chou, J., Yau, V., and Yang, Y. (2005). Gigaxonin-
controlled degradation of MAP1B light chain is critical to neuronal survival. Nature 438,
224-228.
Amiri, M., and Hollenbeck, P. J. (2008). Mitochondrial biogenesis in the axons of vertebrate
peripheral neurons. Dev. Neurobiol. 68, 1348-1361.
Antonellis, A., Lee-Lin, S. Q., Wasterlain, A., Leo, P., Quezado, M., Goldfarb, L. G., Myung, K.,
Burgess, S., Fischbeck, K. H., and Green, E. D. (2006). Functional analyses of glycyl-tRNA
synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
J. Neurosci. 26, 10397-10406.
Avery, M. A., Sheehan, A. E., Kerr, K. S., Wang, J., and Freeman, M. R. (2009). Wld S requires
Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.
J. Cell Biol. 184, 501-513.
Balastik, M., Ferraguti, F., Pires-da Silva, A., Lee, T. H., Alvarez-Bolado, G., Lu, K. P., and Gruss, P.
(2008). Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain
and neurodegeneration.
Proc. Natl. Acad. Sci. USA 105, 12016-12021.
Beetz, C., Schule, R., Deconinck, T., Tran-Viet, K. N., Zhu, H., Kremer, B. P., Frints, S. G., van Zelst-
Stams,W.A., Byrne, P., Otto, S., Nygren, A.O., Baets, J.,
. (2008). REEP1mutation spectrumand
genotype/phenotype correlation in hereditary spastic paraplegia type 31.
et al
Brain 131, 1078-1086.
Beirowski, B., Adalbert, R., Wagner, D., Grumme, D., Addicks, K., Ribchester, R. R., and
Coleman, M. P. (2005). The progressive nature of Wallerian degeneration in wild-type and
slow Wallerian degeneration (WldS) nerves.
BMC Neurosci. 6, 6.
Beirowski, B., Babetto, E., Coleman, M. P., and Martin, K. R. (2008). The WldS gene delays axonal
but not somatic degeneration in a rat glaucoma model.
Eur. J. Neurosci. 28, 1166-1179.
Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., and Mouradian, M. M. (1999).
Degradation of alpha-synuclein by proteasome.
J. Biol. Chem. 274, 33855-33858.
Bomont, P., Cavalier, L., Blondeau, F., Ben Hamida, C., Belal, S., Tazir, M., Demir, E.,
Topaloglu, H., Korinthenberg, R., Tuysuz, B., Landrieu, P., Hentati, F., et al. (2000). The gene
encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in
giant axonal neuropathy. Nat. Genet. 26, 370-374.
Brady, S. T., Lasek, R. J., Allen, R. D., Yin, H. L., and Stossel, T. P. (1984). Gelsolin inhibition of fast
axonal transport indicates a requirement for actin microfilaments. Nature 310, 56-58.
Bridge, K., Berg, N., Adalbert, R., Babetto, E., Dias, T., Spillantini, M. G., Ribchester, R. R., and
Coleman, M. P. (2007). Late onset distal axonal swelling in YFP-H transgenic mice. Neurobiol.
Aging (in press).
Bross, P., Naundrup, S., Hansen, J., Nielsen, M. N., Christensen, J. H., Kruhoffer, M., Palmfeldt, J.,
Corydon, T. J., Gregersen, N., Ang, D., Georgopoulos, C., and Nielsen, K. L. (2008). The Hsp60-
(p.V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin
function both in vitro and in vivo.
J. Biol. Chem. 283, 15694-15700.
Caleo, M., Medini, P., von Bartheld, C. S., and Maffei, L. (2003). Provision of brain-derived
neurotrophic factor via anterograde transport from the eye preserves the physiological responses
of axotomized geniculate neurons.
J. Neurosci. 23, 287-296.
Campbell, D. S., and Holt, C. E. (2001). Chemotropic responses of retinal growth cones mediated by
rapid local protein synthesis and degradation.
Neuron 32, 1013-1026.
Carrel, T. L., McWhorter, M. L., Workman, E., Zhang, H., Wolstencroft, E. C., Lorson, C.,
Bassell, G. J., Burghes, A. H., and Beattie, C. E. (2006). Survival motor neuron function in
motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis.
J. Neurosci. 26, 11014-11022.
Castel, M. N., Beaudet, A., and Laduron, P. M. (1994). Retrograde axonal transport of neurotensin in
rat nigrostriatal dopaminergic neurons. Modulation during ageing and possible physiological role.
Biochem. Pharmacol. 47, 53-62.
